New hope for dizzy migraine sufferers: CGRP drugs under study
NCT ID NCT07203248
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 24 times
Summary
This study looks at whether CGRP-targeted medications can help people with vestibular migraine, a condition where dizziness and vertigo are more common than headaches. Researchers will enroll 2,000 Chinese adults aged 18 to 75 to see if these drugs reduce dizziness severity and frequency. The goal is to find better treatment options for this challenging condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIZZINESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.